Of note, we found three lncRNAs (HPN-AS1, TPTEP1, and LINC00623) could serve as biomarkers for PRAD (Figures 8(a), 8(d), and 8(g)), BRCA (Figures 8(b), 8(e), and 8(h)), and KIRC (Figures 8(c), 8(f), and 8(i)). This evidence concerns the gene HPN and prostate adenocarcinoma.